Next Investors logo grey

Four time Olympian joins Mount Magnet South as technical advisor

Published 31-MAR-2016 11:23 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Mount Magnet South (ASX:MUM), soon to be renamed Impression Healthcare, yesterday added another high profile sports identity to its administration.

Four time Olympian, David Neesham has joined the MMS team as a technical advisor.

Neesham represented Australia four times in Waterpolo career spanning 13 years, but also has vast experience in the field of dentistry.

Next Investors Image

David Neesham is a four-time Olympian.

As MMS, through its Gameday International business, sets out to bring high quality, custom-made, affordable mouthguards to sports clubs across Australia market, it continues to add expertise and sporting nous to its management team.

Neesham is not only an Olympic athlete, he is also a respected Perth dentist, healthcare executive and educator.

His career spans 40 years and includes roles as Principal of Health Services WA’s Dental Therapy Training School and as Director of Dental Services for WA – a role he held for 17 years. IN terms of sports administration, Neesham has served as Chairman of the West Australian Sports Council and has been a Member of the Australian Institute of Sport Advisory Committee.

He is currently on the Board of the Clontarf Foundation, which exists to improve the education, discipline, life skills, esteem and employment opportunities of young Aboriginal men.

“We are delighted to have secured the services of David Neesham,” said Chairman Alex Pismiris.

“His substantial expertise and experience in both dental and sports fields will be highly beneficial to the commercial development of Impression Healthcare and the initial Gameday mouthguard product line. David’s extensive network in the dental industry and the Australian sporting world further complement the reach and access of our highly regarded Management Team including John Worsfold and Matt Weston.”

The appointment of Neesham comes quickly after MMS onboarded NRL favourite Matt Ballin as a Gameday ambassador.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.